Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. PATH’s Dykki Settle joins sector co-authors to offer a brief overview of the digital health landscape, and to highlight how governments, donors, the private sector, multilaterals, and NGOs can accelerate digital transformation.
    Published: February 2022
  2. PATH is one of the World Bank partners responding to India’s medical oxygen crises, providing targeted technical assistance in the states of Andhra Pradesh, Meghalaya, Uttarakhand, and West Bengal.
    Published: January 2022
  3. Ankita Aras, PATH’s director of philanthropic operations, is interviewed in this deep dive on the NGO fundraising landscape.
    Published: December 2021
  4. PATH makes Forbes’ list of America’s top 100 charities. The piece also highlights encouraging trends in charitable giving during the COVID-19 pandemic.
    Published: December 2021

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

970 Item s
970 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release